At a Glance
| Diclazepam | 1,4-Butanediol | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 1–3 mg | 1–2.5 mL |
| Total Duration | 0.2–0.8 hrs | 1.3–3 hrs |
| Routes | oral | oral |
Dangerous Combination
Combining Diclazepam and 1,4-Butanediol is classified as dangerous. Combined CNS depression; risk of respiratory failure
Diclazepam, a Depressant, and 1,4-Butanediol, a Depressant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Depressants, meaning they share a common pharmacological foundation. They share 10 documented effects in common, with 6 effects unique to Diclazepam and 4 unique to 1,4-Butanediol. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Diclazepam | 1,4-Butanediol | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 1–3 mg | 1–2.5 mL |
| Total Duration | 0.2–0.8 hrs | 1.3–3 hrs |
| Routes | oral | oral |
| Effects |
| 16 documented |
| 14 documented |
| Interaction | Dangerous | |
| Level | Diclazepam | 1,4-Butanediol |
|---|---|---|
| Threshold | 0.5 mg | 0.5 mL |
| Light | 0.5–1 mg | 0.5–1 mL |
| Common | 1–3 mg | 1–2.5 mL |
| Strong | 3–4 mg | 2.5–4 mL |
| Heavy | 4 mg | 4 mL |
Diclazepam
1,4-Butanediol
Combined CNS depression; risk of respiratory failure